Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.12% Nasdaq Down 0.07%
Streaming
Ticker Tape: On

More On CGIX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Cancer Genetics, Inc. (CGIX)

-OTC BB

11.60 Down 0.15(1.28%) 3:52PM EDT

Add to Portfolio
Prev Close:11.75
Open:11.80
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:11.40 - 11.80
52wk Range:10.00 - 17.00
Volume:13,496
Avg Vol (3m):3,822
Market Cap:50.07M
P/E (ttm):N/A
EPS (ttm):-7.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Reports

  • No Reports available for CGIX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cancer Genetics, Inc., a genomic technology company, designs, develops, manufactures, and markets DNA-based reagents for cancer diagnosis, prognosis, and disease management. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback